Ten-year survival of patients with locally advanced, stage IB-IIB cervical cancer after neoadjuvant chemotherapy and radical hysterectomy

Gynecologic Oncology

Volumn 82, Issue 1, 2001, Pages 88-93

  Hwang, Youn Yeoung ^a   Moon, Hyung ^a   Cho, Sam Hyun ^a   Kim, Kyung Tai ^a   Moon, Young Jin ^a   Kim, Seung Ryong ^a   Kim, Doo Sang ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; VINBLASTINE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0034939178     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6204     Document Type: Article

References (16)

1. Cervical carcinoma: A drug responsive tumor-Experience with combined cisplatin, vinblastine, bleomycin
2. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor
3. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma
4. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study
5. Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor
6. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell cancer of the cervix
7. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix
8. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
9. Local spread and lymph node involvement in cervical cancer
10. Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix
11. Neadjuvant chemotherapy and radical surgery in locally advanced cervical cancer
12. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: A gynecologic oncology group pilot study
13. Neoadjuvant chemotherapy for locally advanced cervical cancer-where does it stand?: A review
14. Chemotherapy for cancer of the cervix-Current status and its evaluation
15. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection
16. Presurgical prognostic factors in carcinoma of the cervix, stage Ib and IIa